Blau Farmaceutica SA
BOVESPA:BLAU3

Watchlist Manager
Blau Farmaceutica SA Logo
Blau Farmaceutica SA
BOVESPA:BLAU3
Watchlist
Price: 14.7 BRL -2.13% Market Closed
Market Cap: 2.6B BRL
Have any thoughts about
Blau Farmaceutica SA?
Write Note

Blau Farmaceutica SA
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Blau Farmaceutica SA
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Blau Farmaceutica SA
BOVESPA:BLAU3
Short-Term Investments
R$629.5m
CAGR 3-Years
63%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Biomm SA
BOVESPA:BIOM3
Short-Term Investments
R$109.8m
CAGR 3-Years
75%
CAGR 5-Years
13%
CAGR 10-Years
0%
No Stocks Found

Blau Farmaceutica SA
Glance View

Market Cap
2.6B BRL
Industry
Biotechnology

Blau Farmacêutica SA engages in the manufacturing of pharmaceuticals. The company is headquartered in Cotia, Sao Paulo and currently employs 1,700 full-time employees. The company went IPO on 2021-04-19. The firm focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The firm operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.

BLAU3 Intrinsic Value
23.45 BRL
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Blau Farmaceutica SA's Short-Term Investments?
Short-Term Investments
629.5m BRL

Based on the financial report for Dec 31, 2023, Blau Farmaceutica SA's Short-Term Investments amounts to 629.5m BRL.

What is Blau Farmaceutica SA's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
44%

Over the last year, the Short-Term Investments growth was 0%. The average annual Short-Term Investments growth rates for Blau Farmaceutica SA have been 63% over the past three years , 44% over the past five years .

Back to Top